161 related articles for article (PubMed ID: 20523089)
21. A case of bowel perforation after neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
Carter J; Durfee J
Gynecol Oncol; 2007 Dec; 107(3):586-9. PubMed ID: 17949798
[TBL] [Abstract][Full Text] [Related]
22. Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer.
Gouy S; Chereau E; Custodio AS; Uzan C; Pautier P; Haie-Meder C; Duvillard P; Morice P
J Am Coll Surg; 2010 Apr; 210(4):509-14. PubMed ID: 20347745
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy for ovarian cancer: an evidence-based approach.
Geisler JP; Manahan KJ; Wiemann MC
Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
[TBL] [Abstract][Full Text] [Related]
24. Medical treatment of epithelial ovarian cancer.
González-Martín AJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1125-43. PubMed ID: 15606338
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of epithelial ovarian cancer.
Bhoola S; Hoskins WJ
Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
[TBL] [Abstract][Full Text] [Related]
26. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
von Gruenigen V; Daly B; Gibbons H; Hutchins J; Green A
Cancer; 2008 May; 112(10):2221-7. PubMed ID: 18348300
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy for advanced ovarian cancer.
Schwartz PE; Chambers JT; Makuch R
Gynecol Oncol; 1994 Apr; 53(1):33-7. PubMed ID: 8175019
[TBL] [Abstract][Full Text] [Related]
28. Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Williams K; Senterman M; Hopkins L; Faught W; Fung-Kee-Fung M
Gynecol Oncol; 2007 Jul; 106(1):160-3. PubMed ID: 17490737
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors of ovarian cancer].
Ochiai K
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
[TBL] [Abstract][Full Text] [Related]
30. Ovarian cancer chemotherapy.
Christian J; Thomas H
Cancer Treat Rev; 2001 Apr; 27(2):99-109. PubMed ID: 11319848
[TBL] [Abstract][Full Text] [Related]
31. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
[TBL] [Abstract][Full Text] [Related]
32. Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.
Mehta RS
J Clin Oncol; 2008 Jul; 26(19):3286-8; author reply 3288. PubMed ID: 18591566
[No Abstract] [Full Text] [Related]
33. Update on the management of ovarian cancer.
Ozols RF
Cancer J; 2002; 8 Suppl 1():S22-30. PubMed ID: 12075699
[TBL] [Abstract][Full Text] [Related]
34. [Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer].
Meier W; Römisch M; Hepp H
Geburtshilfe Frauenheilkd; 1993 Dec; 53(12):860-5. PubMed ID: 8119569
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic strategies in colorectal cancer].
Flieger D; Keller R; Fischbach W
Dtsch Med Wochenschr; 2003 Sep; 128(37):1902-7. PubMed ID: 12970825
[No Abstract] [Full Text] [Related]
36. Role of chemotherapy in the management of epithelial ovarian cancer.
Reed NS; Sadozye AH
Expert Rev Anticancer Ther; 2005 Feb; 5(1):139-47. PubMed ID: 15757446
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Du Bois A;
Gynecol Oncol; 2007 Jul; 106(1):69-74. PubMed ID: 17397910
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacotherapy in ovarian carcinoma].
Pfisterer J; Du Bois A
MMW Fortschr Med; 2005 Oct; 147(43):34-6. PubMed ID: 16302419
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy improves survival after resection of stage 1 ovarian cancer.
Kitchener HC
Cancer Treat Rev; 2005 Jun; 31(4):323-7. PubMed ID: 15905036
[No Abstract] [Full Text] [Related]
40. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
Sugiyama T; Yoshizaki A; Hatayama S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1011-6. PubMed ID: 17637537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]